A trial fibrillation (AF) increases the risk of ischemic stroke and is the presumed cause of stroke in 20% to 30% of patients with contemporary trends that suggest even higher proportions. [1] [2] [3] Detection of AF after stroke has important therapeutic implications because tailored secondary prevention with vitamin K antagonists or novel oral anticoagulants strongly reduces the risk of future embolic events. 4 Therefore, screening for paroxysmal AF (pAF) during hospitalization for acute stroke is mandatory. Within the past years, great efforts were made to improve diagnostic yield of pAF with prolonged in-hospital ECG monitoring or implantation of external or internal loop recorders. 1, [5] [6] [7] Detection rates increase by ≈2%
to 4% with each additional 24 hours of monitoring. 8 A randomized trial investigating the clinical benefit of prolonged monitoring strategies with regard to prevention of stroke recurrence is currently underway (Impact of Standardized Monitoring for Detection of Atrial Fibrillation in Ischemic Stroke [MONDAFIS] ; NCT02204267).
To offer limited diagnostic resources to patients with the highest likelihood of pAF and to optimize efficiency of ECG monitoring, it would be useful to identify clinical predictors of new AF, which are available on admission. Using data from consecutive patients with ischemic stroke treated on a stroke unit, we aimed to identify predictors of newly detected pAF during in-hospital ECG monitoring and to derive a prediction model.
Methods Study Population, Baseline Characteristics, and Outcomes
From February 2011 to December 2013, all consecutive patients with acute ischemic stroke who were admitted to our stroke unit were prospectively screened for inclusion criteria of the Troponin Elevation in Acute Ischemic Stroke (TRELAS; NCT01263964) study. 9 In brief, patients with imaging-confirmed ischemic stroke who were admitted within 72 hours after symptom onset were registered and screened for elevation of highly sensitive cardiac troponin T (hs-cTnT) on admission. Patients with evidence of AF on admission 12-lead ECG, known medical history of AF, ST-segment-elevation myocardial infarction, endocarditis, pacemaker ECG, and without available hs-cTnT levels on admission were excluded from analysis.
We collected baseline information on patients' demographic (age, sex), as well as risk factors and comorbidities (medical history of coronary artery disease (CAD), congestive heart failure, chronic obstructive pulmonary disease, hyperlipidemia, hypertension, diabetes mellitus, smoking, and previous stroke). Stroke severity was rated using the National Institutes of Health Stroke Scale by certified neurologists. The CHADS 2 score (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke [2P]) and CHA 2 DS 2 -VASc score (congestive heart failure, hypertension, age ≥75years [2P], diabetes mellitus, stroke [2P], vascular disease, age 65-74, sex category female) were calculated from baseline covariates independent of whether the patient had AF. 10, 11 The current stroke event was not included in the calculation.
Hs-cTnT levels were measured using a highly sensitive assay (Roche Elecsys Troponin Ths, Mannheim, Germany) with an upper reference limit for the 99th percentile of the normal reference population at 14 ng/L and a coefficient of variation of <10% at 13 ng/L. Further available laboratory measures included creatine kinase and creatinine. Glomerular filtration rate was estimated using the Chronic Kidney Disease Epidemiology Collaboration formula. 12 Brain lesions were rated for the presence of insular cortex involvement and the presence of multiple lesion pattern (ie, infarcts in >1 major [left carotid, right carotid, and vertebrobasilar] vascular territory). 13 All patients were treated on our certified comprehensive stroke unit for at least 24 hours. Duration of stay on the stroke unit with continuous ECG monitoring was recorded (bedside patient monitor Philips, IntelliVue MP50 with integrated automated algorithm for detection of pAF). Information on newly detected AF was added retrospectively after chart review.
Statistical Methods
To compare patients with and without previously unknown pAF the Mann-Whitney U test was used for continuous variables and the χ 2 test for dichotomous or categorical variables. Multivariable regression analysis was performed using a logistic regression model, and odds ratios as well as the respective 95% confidence intervals for diagnosis of pAF were calculated. All variables associated with previously unknown pAF with a value of P<0.10 in univariate analyses were taken into account for the logistic regression analysis. Because of the skewed distribution of hs-cTnT levels (skewness >10), hs-cTnT was log transferred before being entered into the regression model. The optimal cutoff of hs-cTnT for prediction of new pAF was calculated using the receiver operating characteristics curve analysis and by maximizing the Younden index.
14 Age was entered into the model as a categorical variable according to the CHA 2 DS 2 -VAScscore (age <65, 65-74, and ≥75 years). The predictive performance of the CHADS 2 -or CHA 2 DS 2 -VASc-score alone and with additional variables was compared using c-statistics. Comparisons of c-statistics were done according to the method of deLong. All tests were 2-sided, with a value of P<0.05 considered statistically significant (version 19.0; Statistical Package for the Social Sciences, Chicago, IL). The receiver operating characteristics curve comparisons were calculated using MedCalc software (version 13.1.0; Ostend, Belgium).
Results
In total, 1823 patients with imaging-confirmed ischemic stroke were registered during the study period. Patients were excluded from analysis for the following reasons: (1) AF on admission ECG (n=377), (2) known history of AF (n=146), (3) pacemaker ECG (n=13), (4) ST-segment-elevation myocardial infarction (n=4) or endocarditis (n=10), and (5) no available data on hs-cTnT levels (n=45).
A total of 1228 patients were included in the analysis (median age, 73 years; median National Institutes of Health Stroke Scale, 4; 43.4% women). Previously unknown pAF was detected during in-hospital ECG monitoring in 114 patients (9.3%). Median time of ECG monitoring was 3 days (interquartile range, 2-4 days). Baseline characteristics of patients with and without newly detected pAF are shown in Table 1 . On univariate analysis, higher log hs-cTnT was associated with detection of new pAF during in-hospital ECG monitoring (P<0.001). The optimal cutoff of hs-cTnT for discriminating patients with and without new pAF was 17 ng/L (c-statistics, 0.66; sensitivity 50.0%; specificity, 74.2%). Frequency of insular cortex involvement was significantly higher in patients with newly detected pAF than in those without (45.6% versus 17.8%; P<0.001). Among 250 patients with insular stroke, the right insula was affected in 114 patients (45.6%), the left insula was affected in 136 patients (54.4%). Rate of new pAF was not significantly different between right (18.4%) and left (22.8%) insular strokes (P=0.44). Patients with new pAF were significantly more likely to display insular cortex lesions than patients with known pAF from medical history (45.6% versus 31.7%; P=0.028).
In multivariable logistic regression analysis including all variables associated with pAF in univariate analysis at a value of P<0.10, duration of monitoring, older age, history of hypertension, insular cortex stroke, and higher hs-cTnT levels remained independently associated with pAF (Table 2) . Sensitivity analyses excluding patients with short monitoring episodes (≤1 day; n=146) or with long monitoring episodes (>5 days; n=101) did not change the results meaningfully: older age, insular involvement, higher hs-cTnT levels, and history of hypertension remained the only variables significantly associated with new pAF. Left insular cortex lesions (odds ratio, 3.51; 95% confidence interval, 2.04-6.03; P<0.001) and right insular lesions (odds ratio, 2.46; 95% confidence interval, 1.35-4.49; P=0.003) were both associated with the detection of previously unknown pAF in a multiple regression analysis adjusted for all variables significantly associated with previously unknown pAF.
C-statistics of regression models for detection of new pAF adjusting for the CHADS 2 -score or CHA 2 DS 2 -VASc score with and without further variables are shown in Table 3 . C-statistic for detection of pAF was 0.63 for the CHADS 2 -score and 0.70 for the CHA 2 DS 2 -VASc score. Addition of hs-cTnT or insular involvement to a regression model resulted in significant improvement of the c-statistics compared with a model including the CHADS 2 score or CHA 2 DS 2 -VASc score alone 
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May 2015 (Table 3) . Addition of both hs-cTnT and insular cortex involvement further improved the predictive value, respectively. Similar results were observed when duration of ECG monitoring was accounted for in the regression models although addition of hs-cTnT to the models did not result in significant improvement of the predictive value anymore (Table 3 ).
Discussion
Consistent with previous studies, previously unknown pAF was detected in ≈1 of 10 stroke patients during in-hospital ECG monitoring. 8, 15, 16 Besides longer duration of ECG monitoring, we identified older age, history of hypertension, lesions within the insular cortex, and higher levels of circulating hs-cTnT to be associated with newly detected pAF. A regression model including these variables yielded better discriminative performance for new pAF than both the CHADS 2 -or CHA 2 DS 2 -VASc-score alone. Involvement of the insular cortex was strongly associated with detection of AF in our cohort. In line with our findings, Vingerhoets et al 17 found an association of parietoinsular lesions with previously unknown AF. In a further study, patients with insular infarctions were more likely to develop new arrhythmia (mostly AF) compared with patients without. 18 Recently, isolated small lesions within the insular cortex were associated with newly diagnosed AF. 19 Insular involvement has been linked to larger infarct volumes and higher stroke severity, 18 ,20 which in turn have been repeatedly associated with detection of pAF after stroke. 1, 5, 21 Consequently, strokes with involvement of the insular cortex might be a marker of larger, AF-related emboli resulting in larger lesions. On the contrary, the insula is a part of the central autonomic network and is known to contribute to cerebral control of sympathetic and parasympathetic outflow to the heart. Acute lesions within the insula were shown to cause (proarrhythmic) autonomic imbalance. 22 Consequently, there has been a debate whether AF might be the cause or rather the consequence of insular infarction. 23 More research is needed to define the proportion and relevance of stroke (or insula-)-induced, temporary AF episodes. In addition, more data are required to evaluate the impact of distinct patterns of insular lesions (ie, left/right, anterior/posterior or rostral/caudal) on the genesis of poststroke arrhythmia. Here, we demonstrate an association between higher hscTnT and detection of pAF during in-hospital ECG monitoring. Our findings are corroborated by smaller retrospective studies suggesting that cTn levels on admission measured with conventional assays are more likely to be elevated in ischemic stroke patients with newly detected AF compared with those without. 24, 25 Moreover, in a prospective study on ≈500 patients with stroke, severe episodes of arrhythmia (mainly AF) occurred more often in patients with elevated cTn. 26 Our study suggests that using high-sensitivity cTn assays, already minor elevations might indicate an increased probability of concomitant AF. Cardiac troponins were shown to be associated with structural heart disease and with incident AF in the general population. 27, 28 Given that elevation of hs-cTnT is a common finding in patients with acute tachyarrhythmia, 29, 30 it seems possible that elevated hs-cTnT correlates with recent episodes of pAF preceding the index stroke. Indeed, higher hs-cTnT was shown to be associated with recurrence of AF in patients with sinus rhythm but history of recent AF in the Gruppo Italiano per lo Studio della Sopravvienza nell'Infarto Miocardico (GISSI)-AF trial. 31 Moreover, hs-cTnT was associated with pathological echocardiographic findings like left atrial appendage thrombus and occurrence of future stroke in patients with AF. 29, 32 In contrast to previous studies, history of CAD was not associated with pAF in our cohort. 33 However, the observed association between hs-cTnT and new pAF might indicate a higher prevalence of concomitant (but clinically silent) CAD in the pAF group, given the high frequency of silent CAD in patients with stroke and the association of hs-cTnT levels with extent of CAD. 34, 35 It deserves further investigation whether hs-cTnT may serve as a criterion for application of prolonged ECG monitoring and whether a biomarker-guided approach to facilitate distribution of diagnostic resources is useful.
The CHADS 2 -score was shown to indicate individuals at a risk of new-onset AF and has been suggested for stepwise screening for AF in the elderly. 36, 37 In our cohort, we also observed an association between higher CHADS 2 or CHA 2 DS 2 -VASc-scores and detection of new pAF. However, among the variables composing the scores, only age and hypertension were independently associated with new pAF in this stroke cohort. Consequently, the predictive performance according to c-statistics was rather low, even after addition of monitoring time. Addition of insular cortex lesions or hscTnT or both improved the discriminative power of the models including the CHADS 2 or CHA 2 DS 2 -VASc-scores alone.
Certain limitations of our study have to be stated. First, duration of ECG monitoring differed among the patients. Duration of monitoring is typically longer in critically ill patients, who are usually older and more likely to have larger strokes with insular involvement or hs-cTnT elevation. However, we adjusted for duration of monitoring and performed sensitivity analyses excluding long or short monitoring episodes and the results remained robust. Second, we did not collect data on further cardiac biomarkers, especially biomarkers of myocardial strain like brain natriuretic peptide (BNP). BNP has been shown to be associated with detection of new AF in patients with stroke. 38 Within the Framingham study, BNP levels improved prediction of incident AF during 10-year follow-up beyond clinical variables. 39 Unfortunately, no data on the use of hs-cTnT were available in these studies. Given that levels of hs-cTnT are powerful markers of structural heart disease and correlated with BNP levels in the general population, 27, 35 it is likely that both biomarkers might be useful for identification of patients at risk for pAF. In contrast to BNP, measurement of hs-cTnT is generally recommended by the current American Heart Association/American Stroke Association guidelines for management of patients with acute ischemic stroke 40 and, thus, widely implemented in routine laboratory diagnostics of patients with stroke at baseline. Third, we have no information on echocardiographic findings that were incorporated in previous prediction scores of AF after stroke (ie, left atrial diameter). 21, 41 Of note, higher levels of hs-cTnT were associated with higher left atrial diameter or left atrial abnormalities in patients with AF and has been suggested as a biomarker of thromboembolic risk in these patients. 32 Echocardiographic measurements (ie, left atrial diameter, left ventricular wall thickness, and fractional shortening) were associated with incident AF in the Framingham cohort but did not improve risk prediction beyond clinical parameters. 42 Fourth, admission 12-lead ECG was not recorded systematically. In a recent study, prolonged QTc interval was associated with detection of pAF after stroke. 16 Fifth, the presence of embolic infarct pattern was not recorded in the entire cohort. Consequently, the findings of insula cortex stroke might be biased by the embolic nature. 
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In conclusion, previously unknown pAF was found in 9.3% during in-hospital ECG monitoring in patients with acute ischemic stroke. Longer duration of ECG monitoring, older age, history of hypertension, higher levels of hs-cTnT, and insular cortex involvement were independent predictors of previously unknown pAF in acute stroke. Hs-cTnT and insular cortex involvement may be used to select stroke patients for prolonged or more invasive ECG monitoring. (Table 3) . Addition of both hs-cTnT and insular cortex involvement further improved the predictive value, respectively. Similar results were observed when duration of ECG monitoring was accounted for in the regression models although addition of hs-cTnT to the models did not result in significant improvement of the predictive value anymore (Table 3 ).
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Discussion
Consistent with previous studies, previously unknown pAF was detected in ≈1 of 10 stroke patients during in-hospital ECG monitoring. 8, 15, 16 Besides longer duration of ECG monitoring, we identified older age, history of hypertension, lesions within the insular cortex, and higher levels of circulating hs-cTnT to be associated with newly detected pAF. A regression model including these variables yielded better discriminative performance for new pAF than both the CHADS 2 -or CHA 2 DS 2 -VASc-score alone. Involvement of the insular cortex was strongly associated with detection of AF in our cohort. In line with our findings, Vingerhoets et al 17 found an association of parietoinsular lesions with previously unknown AF. In a further study, patients with insular infarctions were more likely to develop new arrhythmia (mostly AF) compared with patients without. 18 Recently, isolated small lesions within the insular cortex were associated with newly diagnosed AF. 19 Insular involvement has been linked to larger infarct volumes and higher stroke severity, 18 ,20 which in turn have been repeatedly associated with detection of pAF after stroke. 1, 5, 21 Consequently, strokes with involvement of the insular cortex might be a marker of larger, AF-related emboli resulting in larger lesions. On the contrary, the insula is a part of the central autonomic network and is known to contribute to cerebral control of sympathetic and parasympathetic outflow to the heart. Acute lesions within the insula were shown to cause (proarrhythmic) autonomic imbalance. 22 Consequently, there has been a debate whether AF might be the cause or rather the consequence of insular infarction. 23 More research is needed to define the proportion and relevance of stroke (or insula-)-induced, temporary AF episodes. In addition, more data are required to evaluate the impact of distinct patterns of insular lesions (ie, left/right, anterior/posterior or rostral/caudal) on the genesis of poststroke arrhythmia. CI indicates confidence interval; GFR, glomerular filtration rate; hs-cTnT, high-sensitivity cardiac troponin T; NIHSS, National Institutes of Health Stroke Scale; and OR, odds ratio.
*Separate analysis replacing log hs-cTnT for optimal cutoff. †Separate analysis replacing insular involvement for left/right insula.
